Need for a permanent pacemaker after transcatheter aortic valve implantation in Spain: a retrospective analysis of the national Minimum Basic Dataset from 2017 to 2022
View abstract on PubMed
Summary
This summary is machine-generated.The risk of permanent pacemaker implantation after transcatheter aortic valve implantation (TAVI) in Spain increased from 2017 to 2022. This rise was not linked to patient factors or hospital volume, suggesting a need for improved TAVI strategies.
Area Of Science
- Cardiovascular Medicine
- Interventional Cardiology
- Health Services Research
Background
- Limited data exists on permanent pacemaker implantation risk post-transcatheter aortic valve implantation (TAVI) in Spain.
- Understanding this complication is crucial for optimizing TAVI procedures and patient outcomes.
Purpose Of The Study
- To investigate the incidence and temporal trends of permanent pacemaker implantation after TAVI in Spain (2017-2022).
- To identify factors associated with pacemaker implantation following TAVI.
Main Methods
- Retrospective analysis of the Spanish National Hospital Discharge Database (CMBD) from 2017-2022.
- Included patients undergoing TAVI, excluding those under 60 or with prior pacemakers/prostheses.
- Analyzed demographic variables, comorbidities, hospital volume, and pacemaker incidence using multivariable analysis.
Main Results
- A total of 20,826 TAVI procedures were analyzed.
- Pacemaker implantation incidence rose from 15.2% in 2017 to 18.2% in 2022 (p<0.001).
- The increase was independent of age, sex, Charlson Comorbidity Index, and hospital procedural volume.
Conclusions
- The risk of permanent pacemaker implantation after TAVI has significantly increased in Spain.
- This trend is not explained by patient demographics, comorbidities, or hospital procedural volume.
- Optimizing patient selection and TAVI implantation techniques is essential to mitigate this complication.

